Interestingly, there was a notable trend in the proportion of female patients who were converters, 10 of 11 (90.9%), which was seen to a lesser degree in male patients, 7 of 11 (63.6%) included in primary analysis.
← all excerpts
Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management.
1
—
—